Purpose Plant-derived oleanolic acid (OA) and its related synthetic derivatives (Br-OA and Me-OA) possess antihypertensive effects in experimental animals. The present study investigated possible underlying mechanisms in rat isolated single ventricular myocytes and in vascular smooth muscles superfused at 37°C.
Results
OA and its derivatives increased cell shortening in cardiomyocytes isolated from normotensive rats but had no effect in those isolated from hypertensive animals. These triterpenes also caused relaxation in aortic rings and in mesenteric arteries pre-contracted with either phenylephrine or KCl-enriched solution. The relaxation was only partially inhibited by endothelium denudation, and also partly inhibited by the cyclooxygenase (COX) inhibitor indomethacin, with no additional inhibitory effect of the NO synthase inhibitor, N-ω-Nitro-Larginine. A combination of both ATP-dependent channel inhibition by glibenclaminde and voltage-dependent K + channel inhibition by 4-aminopyridine was necessary to fully inhibit the relaxation.
Introduction
Hypertension is a highly prevalent cardiovascular condition and constitutes a major risk factor for other cardiovascular diseases [1] . Cardiovascular-related mortality and morbidity pose a heavy burden on health systems, especially in conditions of limited resources in low and middle-income countries [2] . Although there are currently many effective anti-hypertensive drugs, these remain relatively inaccessible to the poor communities due to high cost, especially since the majority of the patients require more than one therapeutic drug. There is, therefore, a need to find cheaper therapeutic alternatives. Plant-derived extracts have been used as therapeutic agents for hundreds of years by many cultures because of their accessibility [3] [4] [5] . However, research is needed to validate the efficacy and the action mechanisms of these plant extracts, including those with beneficial effects on hypertension. There is great interest in plant derived triterpenes, including oleanolic acid (OA), which possess multiple beneficial systemic (antiinflammatory, immunomodulatory, antitumor, antidegenerative, antidiabetic) or organ-specific (renoprotective, cardioprotective, hepatoprotective) effects (for references see [6] ). We have previously demonstrated that Syzygium aromaticum-derived oleanolic acid (OA) and related triterpene derivatives possess antihypertensive effects in experimental models of hypertensive animals [7, 8] . In particular, we have shown that these triterpenes have marked natriuretic and antioxidant actions, particularly in Dahl-salt sensitive (DSS) and spontaneously hypertensive rats (SHR) [8] . The natriuretic action was not accompanied by an effect on diuresis, excluding any effect on intravascular filling. Hence, the interest of this study was to further investigate the mechanisms of blood pressure-lowering properties of OA and related oleanane derivatives, and more specifically to examine potential cardiac and vascular effects. Vascular smooth muscle contraction and relaxation result from the increased phosphorylation and dephosphorylation, respectively, of myosin light chains. Increased phosphorylation is mediated by the increased activity of a calmodulin-dependent myosin light chain kinase (MLCK) and by the decreased activity of phosphatases (PP). This occurs following the increase of the cytosolic Ca 2+ concentration ([Ca   2+ ] c ) either upon opening of sarcolemmal Ca 2+ channels by membrane depolarization or upon Ca 2+ release from intracellular stores following the formation of inositol-triphosphate (IP 3 ) by agonists coupled to phospholipase C. Hyperpolarization following the opening of various types of K + channels causes relaxation by deactivating the Ca 2+ channels, and the role of K + channels in relaxation can be tested using K + channels blockers. MLCK or PP enzyme activities and hence smooth muscle contraction can also be modulated by various signaling pathways, including those involving intracellular nucleotides (such increases of intracellular cGMP or cAMP, mediated by NO and by cyclooxygenase (COX) products, respectively) but also nucleotide-independent cascades. The role of these pathways can be tested by inhibiting key enzymes involved in the signaling cascade. The aim of our study was to examine the possible role of cardiac negative inotropic and/or vasculo-relaxant effects of OA and derivatives as mechanisms underlying the blood pressure-lowering properties of these agents. In particular, we wanted to examine the pathways implicated in these effects. Therefore we tested the role of ATP-dependent potassium channels in OA and derivative-induced relaxation using glibenclamide, and that of voltage-dependent channels using 4-amino-pyridine. NO formation was blocked by a non-specific NO synthase (NOS) inhibitor, and COX was inhibited by indomethacin. 4 ) derivatives were synthesized as described previously [8] . Stock solutions of these drugs were prepared in DMSO and were diluted to the final experimental concentration (0.1 μM-1 mM) by dissolving in the cell or tissue superfusing solutions (see below).
Materials and Methods

Chemicals
Animals
Male Wistar and Dahl salt-sensitive (DSS) rats (250-300 g) were purchased from Charles River Laboratories Inc. (Wilmington, MA, United States of America) and housed in the Animalium of the University of Leuven. The rats were maintained on a 12 h light / dark regime and had free access to both food and water. The DSS rats were fed high salt Na + diet (8%) (Bio Services, Berlin, Germany) from the age of 4 up to 10 weeks. All experimental protocols were reviewed and approved by animal ethics committees of KULeuven (4500768204) and UCL (2012/MD/ UCL/004).
Cardiac cell and vascular tissue isolation
Ventricular cardiomyocyte isolation. The methods for cell dissociation and electrophysiological measurements were similar to those described previously [9] . Briefly, rats were injected with heparin (70-85 mg kg -1 i.p) 10 min before sacrifice, and they were euthanized by injection with pentobarbital (150-300 mg kg -1 i.p). The chest was cut open and the heart immediately removed and placed in ice-cold cardioplegic solution containing 27 mM KCl and 50 mM glucose to arrest contraction and protect against metabolic consequences of hypoxia during cannulation of the aorta. The heart was then mounted on the perfusion system and was initially perfused with normal Tyrode solution of the following composition in mM: 135 NaCl, 5. -and enzyme-free solution to stop the enzyme digestion, and 5) perfusion with Tyrode solution into which Ca 2+ was gradually reintroduced up to a concentration of 0.18 mM. The ventricles were cut out into the latter solution and cells were dissociated by gentle mechanical agitation and filtered through a mesh (200 μm hole diameter). Cells were given time to settle down at room temperature before use for measurements. Vascular tissue isolation. The methods for vascular tissue isolation, contraction and relaxation measurements were similar to those described previously [10] . Briefly, male Wistar and DSS rats (250 g) were sacrificed by stunning and exsanguination. Aorta 
Measurements
Cell shortening in cardiac myocytes. Cells were placed in a chamber mounted on the stage of an inverted microscope (Olympus X-70) and superfused with Tyrode solution at 35°C. The cells were field-stimulated with 2.5 ms pulses at a frequency of 1 Hz (Myopacer Cell Stimulator, IonOptix, Milton, USA). A video-based edge detector (Crescent, Salt Lake City, USA) was used to capture and convert changes in cell length during contraction and relaxation into an analog voltage signal. Tyrode solution containing OA or derivatives was superfused at different time intervals during the experimental period. The magnitude of cell contraction was assessed by measuring the amplitude of cell shortening, the kinetics of contraction development by measuring the time-to-peak contraction (TTP) and the kinetics of relaxation by measuring the time constant (tau) of the late, exponential relengthening. Cell contraction is expressed as percentage shortening relative to the resting cell length.
Ca 2+ current measurements. In a few cells, preliminary studies were carried out to examine whether the inotropic effects of the drugs could be accounted for by an effect on the L-type Ca 2+ current (I CaL ). For this purpose, whole cell currents were recorded with the patch-clamp technique at room temperature using patch pipettes pulled from capillary glass (GB 200-8P; Science Products, Hofheim, Germany) on a DMZ Universal Puller (Zeitz-Instrumente, Munich, Germany), with a final resistance of 2-4 MO when filled with internal solution of the following composition in mM: 130 CsCl, 25 TEA-Cl, 1 MgCl 2 , 5 Na 2 ATP, 0.1 Na 2 GTP, 1 EGTA, 5 HEPES, pH adjusted to 7.25 with CsOH. The voltage-clamp protocol consisted of a pre-step from the holding potential of -70 mV to -50 mV to inactivate voltage-dependent Na + channels, followed by 200 ms depolarizing voltage steps to various levels between -40 and +70 mV to activate I Ca . In these experiments, the cells were superfused and internally dialyzed with Cs-based solutions in order to block K + currents [9] .
Isometric tension and vasodilatory effects. Aortic rings were mounted under a tension of 20 mN in a 12.5 mL organ-bath. Mesenteric arteries were mounted in a wire myograph (DMT, Aarhus, Denmark) under the tension determined by the normalization procedure [11] in a 6 mL organ bath. The baths were perfused with PSS and gassed with 95% O 2 and 5% CO 2 at 37°C. Artery rings were first stimulated with low-NaCl high-KCl PSS of the following composition in mM: 31.9 NaCl, 94 KCl, 25 NaHCO 3 , 11.5 glucose, 1.2 NaH 2 PO 4 , 1.2 MgCl 2 and 2.5 CaCl 2 in order to assess vessel integrity. A washout and recovery period of 15 min was allowed before starting the experiment.
Aortic rings and SMA with and without functional endothelium were pre-contracted with a single sub-maximal concentration of KCl (50 mM) or phenylephrine (PE; 5 μM). When a sustained and stable contraction was observed, cumulative concentration-response effects were measured upon sequential exposure to carbachol (CCh; 0.01-100 μM), to test the presence of a functional endothelium, or to OA and derivatives (0.1 μM-1 mM). Endothelium-denuded vessels were recognized by the absence of a significant response to the addition of CCh (residual contraction larger than 90% of the maximum contraction). Each drug concentration was left in contact with the vessels for 2 min. The contractile tension was measured using data acquisition hardware and software (Myodacq 2.01, DMT, Aarhus, Denmark). Following each concentration-response curve the vessels were washed with PSS and let to recover in PSS for 15 min. The involvement of NO and/or COX in triterpene-induced effects was examined in intact aortic rings and SMA pre-treated with N-ω-Nitro-L-arginine (L-NoARg; 100 μM) a NOS inhibitor, and/or with indomethacin (INDO; 10 μM), a non-selective COX inhibitor for 30 minutes. To assess a possible involvement of K + channels in the effects of OA and derivatives, isolated vessels were pretreated with the ATP-dependent K + channel blocker glibenclamide (Gli, 5 mM) or/and with the voltage-activated K + channel blocker 4-aminopyridine (4-AP;
1 mM). The drug concentrations used cause maximal blockade of the targeted channels.
Data analysis
Data analysis for cardiac studies was performed using Clampfit 8.2 (Axon Instruments, Scotland) and Origin (Origin lab, USA). Differences between groups were analyzed for statistical significance using ANOVA with a Fisher post-hoc test, using Statistica 7.1 (StatSoft, USA). Vascular studies data were analyzed using GraphPad InStat (version 5.00, GraphPad Software, San Diego, CA, USA). Statistical comparison of the differences between the control and experimental groups was performed with a two-way analysis of variance, followed by a Bonferroni multiple comparison test. All data are expressed as mean ± standard error of the mean (SEM). When comparing data, a difference with p < 0.05 was considered as significant.
Results
Effects on cardiomyocyte shortening Beside peak amplitudes (left column graph of each panel), kinetic parameters, namely the time-to-peak (middle column graph of each panel) and the time constant of the late relaxation phase (right column graph of each panel), were also measured. It is to be noted that there were marked differences in these kinetic parameters between ventricular myocytes from Wistar rats and those from DSS rats. Time to peak (TTP) and relaxation time constants were significantly (p < 0.0001) increased in cells from the hypertensive animals compared to the cells from normotensive Wistar rats. OA and its derivatives had no effects on these kinetics parameters, even in cells from Wistar rats where contraction amplitude increased.
A few preliminary experiments were conducted to test whether an increase in Ca 2+ currents can account for the positive inotropic effect observed in Wistar rats. In ventricular myocytes (n = 6), OA had no significant effects on the Ca 2+ current measured using the whole-cell patch-clamp technique (at 0 mV: control 591.0 ±36.55 pA vs OA 556.4 ±32.60 pA). Because of the above findings further work focused on vascular effects.
Effects on vascular smooth muscles
The potential vasodilating properties of OA and derivatives was evaluated in rat aortic rings (mounted in classical organ baths) and in 2 nd to 3 rd order mesenteric arteries (mounted in wire-myographs). Experiments were performed in endothelium-intact and denuded vessels to discriminate between endothelium-dependent and -independent mechanisms, or in the presence of various inhibitors to determine the signaling pathways or effectors involved.
Comparison of the vasodilating effects of OA and derivatives. Addition of OA, Me-OA or Br-OA on endothelium-intact mesenteric arteries pre-contracted with KCl-enriched solution (Fig 2A and 2C) or PE (Fig 2B) evoked a significant relaxation of the arterial segments isolated from Wistar rats. Similarly, these drugs also induced relaxation in aortic rings (Fig 2D  and 2E ), but the effects were clearly less marked than in the mesenteric arteries (e.g. p < 0.001, for the maximum relaxation evoked by Br-OA in PE pre-contracted mesenteric vessels vs aorta vessels; p < 0.001 for KCl pre-contracted arteries). When comparing the effects of the three drugs, Br-OA showed a significantly larger maximum relaxation than OA and Me-OA. This difference, however, was not apparent in the aortic rings.
A similar pattern in relaxation with all the three drugs was observed in arterial segments isolated from DSS rats (Fig 3) . There was no difference in the magnitude of relaxant effects of OA and derivatives in Wistar and DSS isolated vessels (e.g. % residual contraction of PE-precontraction of mesenteric arteries 22.03 ±3.43% in Wistar vs. 31.13 ±7.33% in DSS and aortic rings 62.83 ±7.26% in Wistar vs. 63.89 ±4.88% in DSS with 10 −3 M Br-OA; n = 7; p > 0.05). Further experiments to evaluate the mechanisms of vasorelaxation properties of OA and derivatives were conducted in arterial segments isolated from Wistar rats only. Endothelium-dependent vasorelaxant effects of OA and derivatives. The relaxation evoked by OA and derivatives was only partially inhibited in the absence of functional endothelium as shown in endothelium-denuded vascular rings experiments (Fig 4, shown only for Br-OA, p < 0.05 for mesenteric vessels; p < 0.001 for aorta; results for OA and Me-OA presented in S1 and S2 Figs respectively). This indicates that the relaxation-evoked by OA or derivatives involves both endothelium-dependent and independent mechanisms.
In order to characterize the endothelium-dependent relaxation, endothelium-intact vessels were incubated in the presence of the COX inhibitor INDO or of the NOS inhibitor L-NoArg. As shown in Fig 4, incubation with INDO blocked Br-OA-evoked relaxation to the same extent as removal of the endothelium (p < 0.05 for absence vs. presence of INDO in mesenteric arteries; p < 0.001 for aorta). Addition of L-NoArg did not further inhibit the COX-resistant relaxation. Qualitatively similar results were observed with OA and Me-OA (see S1 and S2 Figs). In a limited number of experiments, vessels were exposed to L-NoArg in the absence of INDO (see S1 Table) without any significant inhibition of the relaxation to OA or derivatives. These data are in favor of an involvement of COX and prostanoids-dependent mechanisms, and against the implication of NOS/NO-dependent pathways.
Endothelium-independent vasorelaxant effects of OA and derivatives. As observed above (Fig 4) , a significant portion of the relaxation evoked by OA and derivatives is resistant to removal of the endothelium suggesting a role of endothelium-independent pathways. To investigate the possible involvement of K + channels, denuded vessels were incubated in the presence of glibenclamide (Gli) to block ATP-dependent K + channels, and of 4-aminopyridine OA and Me-OA in S5 and S6 Figs respectively). These data suggest that ATP-dependent and voltage-activated K + channels opening mediate the endothelium independent relaxation.
Discussion
The present study was carried out to further investigate the mechanisms of blood pressure lowering effects of OA and related synthetic derivatives. Previous studies have documented a marked natriuretic action of these drugs in vivo [7, 8, 12 ]. The present study shows that OA and synthetic derivatives do not decrease but rather increase myocyte shortening in cells isolated from normotensive rats but not in cells isolated from hypertensive animals. The study also confirms previous observations that OA possesses vasorelaxant properties in the aorta and in mesenteric arteries [13, 14] , and extend these properties to the two synthetic derivatives, Br-OA and Me-OA. Cardiac function is one of the factors that regulate mean arterial pressure (MAP), and an effect on the heart, such as a decrease of the heart rate or of the stroke volume, could also contribute to the blood pressure lowering effect of OA and its derivatives. No or mild effects on heart rate have been reported for the compounds in previous studies [15, 16] , indicating that bradycardia cannot account for the marked decrease in MAP obtained with the drugs. In the absence of a change in heart rate, a decrease of cardiac output and MAP can be brought about by a change in stroke volume. Such a decrease of stroke volume is unlikely because OA and derivatives did not cause any negative inotropic effect.
In cells isolated from DSS rats the time to peak and relaxation time was higher than that of cells from normotensive rats. Cardiac hypertrophy and heart failure caused by high blood pressure reduce the ability of Ca 2+ to trigger calcium release from the sarcoplasmic reticulum [17] . This, in addition to the decreased sarcoplasmic reticulum Ca 2+ uptake [18] may explain the delayed time-to-peak and relaxation in cardiomyocytes from DSS rats. OA and derivatives had no apparent effect on shortening in these animals, indicating that the mechanism underlying the OA and derivatives-induced positive inotropic effect in Wistar rats is deficient in DSS animals. The mechanism underlying this positive inotropic effect was not clarified. We did not observe any increase of L-type Ca 2+ currents. The experiments on I Ca were carried out at room temperature, using cardiomyocytes dialyzed under whole-cell patch-clamp conditions. Additional studies using cells with preserved intracellular medium (under perforated patch conditions) and at 37°C are needed before completely excluding a mechanism involving L-type Ca 2+ currents. In any case, our study suggests that a negative inotropic action, resulting in a decrease of stroke volume, is excluded as a mechanism for the hypotensive action of OA and derivatives. On the other hand, increased cardiomyocyte contractility implies an increase in cardiac output, an effect which may be beneficial for a drug which causes natriuresis and vasodilation. The relaxation evoked by OA and derivatives was only partially inhibited in endotheliumdenuded vascular rings. This demonstrates that in our experimental setting the relaxation involves both endothelium-dependent and independent mechanisms. Other reports suggest that OA-induced relaxation is nearly fully endothelium-dependent and is associated with an increased production of NO since relaxation was marginal in endothelium-denuded vessels and it could be abrogated by NO synthase inhibitors or by NO scavengers [19] . Our results are thus in contradiction with these previous findings, despite the fact that the various studies used the same types of vessels (aorta and mesenteric arteries) from the same species (rat). There is no clear explanation for this discrepancy. However, the same research groups also reported substantial (~34%) endothelium-resistant relaxation [14, 20] . One possible reason for the difference might be due to the fact that in our study we tested the relaxation in PE-precontracted vessels. PE was also the agonist used to contract the vessels in the above-mentioned studies which also reported substantial endothelium-resistant relaxation [14, 20] . This is in contrast with the studies where the vessels were precontracted with norepinephrine [19] . Previous studies have noted that vascular effects of norepinephrine may not only implicate the effects on alphaadrenergic receptors, but also effects due to beta-adrenergic receptors and in addition effects due to non-adrenergic (e.g. dopaminergic) receptors. Therefore, despite the fact that the use of norepinephrine is a better mimic of the physiological conditions, phenylephrine might be more appropriate when deciphering the mechanisms involved in drug action [21] . Noteworthy, our results demonstrate that the endothelium-dependent fraction of the relaxation to OA and derivatives is abrogated in the presence of COX inhibitor attesting the implication of a prostanoiddependent pathway. Our results corroborate previous studies [22] suggesting that OA promotes prostaglandin I 2 release from vascular smooth muscle cells albeit in a different time-scale.
Pathways underlying the endothelium-independent relaxation evoked by OA and derivatives may implicate the opening of the K + channels. Therefore, we tested this hypothesis in denuded vessels incubated in the presence of blockers of different K + channels types (Gli for ATP-dependent K + channels and 4-AP for voltage-activated K + channels). Either inhibitor when applied alone blunted part of the relaxation evoked by OA and derivatives. The effects of both inhibitors were additive and their simultaneous application allowed a complete blockade of the relaxation to OA, Br-OA and Me-OA, indicating that ATP-dependent and voltage-activated K + channel opening in vascular smooth muscle mediate the endothelium independent relaxation. The present study tested whether two synthetic derivatives of OA display effects similar to those of the parent compound. Interestingly, the maximum relaxation evoked by one of the derivatives, Br-OA, was significantly larger in the mesenteric vessels although these differences were not observed in the aorta. The difference seems to be largely due to the endothelium-independent component but the mechanism underlying the larger efficacy of Br-OA is not known. We speculate that this variation in relaxation profiles of these compounds is probably due to differences in the effects on receptors or effectors (e.g. channels) present.
The OA or derivatives-induced vasodilatation is expected to result in the decrease of total peripheral resistance which could be implicated in the blood pressure lowering effect of these triterpenes. However, in vivo studies indicate that OA, Br-OA or Me-OA acutely decrease blood pressure to a similar extent [8] . A similar hypotensive effect is not expected if Br-OA is more efficacious at inducing the vasodilatatory action as suggested by the present study. Additional factors may contribute to or interfere with the vasodilatatory action. We speculate that the previously reported improved Na + elimination caused by these compounds could interact with these effects on vascular function. Natriuresis without increased diuresis as was obtained in our in vivo studies [8] is expected to induce a decrease in extracellular Na + concentration which can affect transmembrane Na + gradients and influence the activity of the Na + -Ca 2+ exchanger, resulting in changed Ca 2+ movements via this pathway. The resulting changes in intracellularly available Ca 2+ could influence relaxation and hence affect the other mechanisms that decrease vascular resistance.
In conclusion, the present study provides evidence that OA, Me-OA and Br-OA possess vasodilatory actions mediated in part by the endothelium-dependent COX/prostanoids pathway, but also in part by endothelium-independent opening of ATP-dependent and voltageactivated K + channels. It sheds further light on possible mechanisms for the antihypertensive effects of OA and related synthetic oleanane derivatives, which may involve a decrease in vascular resistance.
Supporting Information (TIF) S1 Table. Role of endothelium in response to OA, Me-OA and Br-OA. Preliminary concentration-responses for OA, Me-OA, and Br-OA (30 μM) in endothelium-intact mesenteric arteries or aortic rings isolated from Wistar rats, pre-contracted with sub-maximal concentration of PE (5 μM). Vessels were incubated in the presence of L-NoArg (100 μM) prior to addition of the drug. The values shown are means ± SEM (n = 6).
